ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

New ACS Awards Total $18.4 Million

February 23, 1979

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014

Cancer Death Rates Declined 2.1 Percent Per Year.

October 19, 2007

AACR Honors Scientists: Opens Web Sites

May 10, 1996

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010